Stories

There is a difference between telling people to stop smoking and giving them a route that works. Safer nicotine alternatives may not fit the traditional idea of quitting, but they can still reduce exposure to the smoke that causes most tobacco-related disease. For adults who continue to smoke, that difference matters. Harm reduction is about progress that people can actually achieve.

Flavour bans promise simple solutions, but the real-world evidence is far less convincing. When smoke-free products become less appealing or harder to access, adult smokers may lose one of the reasons switching away from cigarettes works. Youth protection should be taken seriously, but policy must also consider unintended consequences: illicit markets, reduced switching and a return to smoking. A ban is not a success if it removes options without reducing harm.

False claims about smoke-free nicotine products do not make people safer — they can keep people smoking. When adults are told that lower-risk alternatives are just as harmful as cigarettes, confusion replaces informed choice and the incentive to switch weakens. Misinformation protects the product causing the greatest harm: combustible tobacco. Public health needs honesty about risk, not messages that make all nicotine products look the same.

Sweden’s success in reducing smoking should be studied, not sidelined. By allowing adults access to smoke-free nicotine alternatives, the country has shown that tobacco control can move faster when policy reflects relative risk. If regulators ignore that lesson, they risk protecting outdated approaches while smokers elsewhere are denied more practical routes away from cigarettes. The goal should be less disease and fewer deaths — not loyalty to one narrow model of quitting.

When tobacco policy preserves the status quo, the most harmful product remains protected. Cigarettes stay familiar, available and profitable, while lower-risk alternatives face suspicion, restriction and misinformation. The result is a system that talks about reducing smoking but often makes switching harder in practice. Public health should be willing to challenge the incentives that keep combustion at the centre of the market.

Flavour bans sound simple, but their effects are not. For many adults, flavours help make vaping a more acceptable substitute for cigarettes — and removing them may push people back towards smoking or into unregulated markets. Protecting young people requires strong enforcement and responsible retail controls, not policies that remove useful options for adults trying to quit. A ban that weakens switching while doing little to stop youth access is not good public health.

Ireland’s stalled smoking decline should prompt a serious rethink of vape policy. When progress slows, restricting the very products that may help adults move away from cigarettes risks making the problem harder to solve. Youth protection matters, but it should not come at the cost of leaving smokers with fewer practical alternatives. A better approach would focus on enforcement, accurate risk communication and regulated access to lower-risk products.

The status quo in tobacco policy has winners — and they are rarely the smokers who need better options. When cigarettes remain easy to buy while safer nicotine products are restricted, taxed or stigmatised, the market continues to favour combustion. Public health should ask who benefits when harm reduction is blocked and misinformation spreads. A system that preserves cigarette use while limiting alternatives is not neutral; it protects the most harmful product by default.

The Commission's response to the French nicotine pouch ban overlooking internal market principles is concerning. Mutual recognition allows products lawfully sold in one EU country to be sold in another. However, the Commission's approval of France's ban on oral nicotine products contradicts this. Nicotine pouches are considered less harmful than cigarettes, as evidenced by the FDA's reviews. The ban disregards scientific evidence and treats pouches as equally risky as cigarettes, which is not supported. Better regulation, proportionality, and evidence-based policies are needed. France's ban challenges EU principles, and the Commission should reassess its stance to protect consumer access to lower-risk alternatives.

International experts warn of an anti-science campaign misrepresenting safer nicotine products, leading smokers to believe vaping is as harmful as smoking. The false perceptions hinder smokers from switching to less harmful alternatives, increasing health risks. Surveys show a growing number of smokers hold misconceptions about vaping, with many believing it is as harmful as smoking. Few smokers are aware that vaping is less harmful. Dr. Delon Human stresses the importance of accurate information and access to safer alternatives, citing Sweden's success in reducing smoking rates through such measures. Mistaken beliefs about vaping's dangers fuel a deadly cycle of cigarette addiction.